James Gilligan

James Gilligan

President chez
Tryp Therapeutics, Inc.
74 ans
Health Technology
Consumer Services
Commercial Services

Profil

James Patrick Gilligan was the founder of Unigene Laboratories, Inc. (founded in 1981) where he held the title of Vice President-Product Development.
He was also the founder of Herborium Group, Inc. (founded in 2002) where he held the titles of Co-President, Chief Operating Officer & Director.
Additionally, he was the founder of Tarsa Therapeutics, Inc. (founded in 2009) where he held the title of Chief Scientific Officer.
Dr. Gilligan is also the founder of The Bracken Group LLC.
Dr. Gilligan's current job is as the President & Chief Scientific Officer at Tryp Therapeutics, Inc. (since 2020).
His former jobs include being the Managing Partner at Solenture LLC (2018-2020) and the Principal at Taurus Development Group, Inc. (2018-2019).
In terms of education, Dr. Gilligan attended Bates College for his undergraduate degree, Seton Hall University for his graduate degree, and the University of Connecticut for his doctorate.

Postes actifs de James Gilligan

SociétésPosteDébut
President 01/11/2020

Anciens postes connus de James Gilligan

SociétésPosteFin
HERBORIUM GROUP, INC. Fondateur 01/06/2022
Corporate Officer/Principal 01/11/2020
Corporate Officer/Principal 01/12/2019
Fondateur 01/02/2018
Fondateur -
Voir l'expérience en détail de James Gilligan

Formation de James Gilligan

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

6

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Industrial Services

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. James Gilligan